2q31.1 microdeletion syndrome

Last reviewed

🖨 Print for my doctorAdvocacy Hub →
ORPHA:251014Q93.5
Who is this for?
Show terms as
8Treatment centers

Where are you in your journey?

UniteRare data is sourced from FDA.gov, ClinicalTrials.gov, Orphanet, OMIM, and NORD.
Report missing data

Overview

2q31.1 microdeletion syndrome is a rare chromosomal disorder caused by a small deletion (microdeletion) on the long arm of chromosome 2 at band 31.1. This region contains several genes critical for limb and skeletal development, including the HOXD gene cluster. The syndrome is characterized by variable clinical features depending on the size and exact location of the deletion. Key features typically include limb anomalies (particularly affecting the hands and feet, such as brachydactyly, syndactyly, or split hand/foot malformation), intellectual disability of variable severity, growth retardation, and distinctive facial features. Facial dysmorphisms may include a prominent forehead, short nose, thin upper lip, and micrognathia. Some patients also present with congenital heart defects, genitourinary anomalies, and feeding difficulties in infancy. The severity of the condition varies considerably among affected individuals, largely depending on which genes are encompassed by the deletion. Deletions that include the HOXD gene cluster are more commonly associated with significant limb malformations, while deletions sparing this cluster may present with milder skeletal involvement but still feature developmental delay and intellectual disability. Additional clinical findings may include hypotonia, speech and language delay, and behavioral difficulties. There is currently no cure for 2q31.1 microdeletion syndrome. Management is supportive and multidisciplinary, tailored to the individual's specific symptoms. This may include orthopedic interventions for limb anomalies, speech therapy, occupational therapy, special educational support, and cardiac or urological management as needed. Early intervention programs are recommended to optimize developmental outcomes. Genetic counseling is advised for affected families.

Also known as:

Clinical phenotype terms— hover any for plain English:

Inheritance

Autosomal dominant

Passed on from just one parent; each child has about a 50% chance of inheriting it

Age of Onset

Neonatal

Begins at or shortly after birth (first 4 weeks)

Orphanet ↗NORD ↗

Treatments

No FDA-approved treatments are currently listed for 2q31.1 microdeletion syndrome.

View clinical trials →

No actively recruiting trials found for 2q31.1 microdeletion syndrome at this time.

New trials open frequently. Follow this disease to get notified.

Search ClinicalTrials.gov ↗Join the 2q31.1 microdeletion syndrome community →

No specialists are currently listed for 2q31.1 microdeletion syndrome.

View NORD Rare Disease Centers ↗Undiagnosed Disease Network ↗

Treatment Centers

8 centers
🏥 NORD

Baylor College of Medicine Rare Disease Center

Baylor College of Medicine

📍 Houston, TX

🏥 NORD

Stanford Medicine Rare Disease Center

Stanford Medicine

📍 Stanford, CA

🔬 UDN

NIH Clinical Center Undiagnosed Diseases Program

National Institutes of Health

📍 Bethesda, MD

🔬 UDN

UCLA UDN Clinical Site

UCLA Health

📍 Los Angeles, CA

🔬 UDN

Baylor College of Medicine UDN Clinical Site

Baylor College of Medicine

📍 Houston, TX

🔬 UDN

Harvard/MGH UDN Clinical Site

Massachusetts General Hospital

📍 Boston, MA

🏥 NORD

Mayo Clinic Center for Individualized Medicine

Mayo Clinic

📍 Rochester, MN

👤 Mayo Clinic Center for Individualized Medicine

🏥 NORD

UCLA Rare Disease Day Program

UCLA Health

📍 Los Angeles, CA

Travel Grants

No travel grants are currently matched to 2q31.1 microdeletion syndrome.

Search all travel grants →NORD Financial Assistance ↗

Community

Open 2q31.1 microdeletion syndromeForum →

No community posts yet. Be the first to share your experience with 2q31.1 microdeletion syndrome.

Start the conversation →

Latest news about 2q31.1 microdeletion syndrome

No recent news articles for 2q31.1 microdeletion syndrome.

Follow this condition to be notified when news becomes available.

Caregiver Resources

NORD Caregiver Resources

Support, advocacy, and financial assistance for caregivers of rare disease patients.

Mental Health Support

Rare disease caregiving can be isolating. Connect with counseling and peer support.

Family & Caregiver Grants

Financial assistance programs specifically for caregivers of rare disease patients.

Social Security Disability

Learn how rare disease patients may qualify for SSDI/SSI benefits.

Common questions about 2q31.1 microdeletion syndrome

What is 2q31.1 microdeletion syndrome?

2q31.1 microdeletion syndrome is a rare chromosomal disorder caused by a small deletion (microdeletion) on the long arm of chromosome 2 at band 31.1. This region contains several genes critical for limb and skeletal development, including the HOXD gene cluster. The syndrome is characterized by variable clinical features depending on the size and exact location of the deletion. Key features typically include limb anomalies (particularly affecting the hands and feet, such as brachydactyly, syndactyly, or split hand/foot malformation), intellectual disability of variable severity, growth retardat

How is 2q31.1 microdeletion syndrome inherited?

2q31.1 microdeletion syndrome follows a autosomal dominant inheritance pattern. Genetic counseling can help families understand recurrence risk and testing options.

At what age does 2q31.1 microdeletion syndrome typically begin?

Typical onset of 2q31.1 microdeletion syndrome is neonatal. Age of onset can vary across affected individuals.